Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Inman

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 3, 1999
Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonistK N Parameswaran, M D Inman, B P Ekholm, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 27, 2008
Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison studyJ A Hirota, K Ask, D Fritz, et al.
Mucosal Immunology|August 16, 2013
Amelioration of ovalbumin-induced allergic airway disease following Der p 1 peptide immunotherapy is not associated with induction of IL-35D M Moldaver, M S Bharhani, J N Wattie, et al.
The Journal of Clinical Investigation|September 17, 1998
Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophiliaJ Wang, K Palmer, J Lŏtvall, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 17, 2015
T regulatory cell phenotypes in peripheral blood and bronchoalveolar lavage from non-asthmatic and asthmatic subjectsA J Baatjes, S G Smith, R Watson, et al.
Canadian Respiratory Journal|September 12, 2000
Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markersK Parameswaran, M D Inman, R M Watson, et al.
The European Respiratory Journal. Supplement|October 4, 2002
The use of induced sputum in clinical trialsJ C Kips, M D Inman, L Jayaram, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 10, 2002
Inhalation of a harmless antigen (ovalbumin) elicits immune activation but divergent immunoglobulin and cytokine activities in miceF K Swirski, B U Gajewska, D Alvarez, et al.
The European Respiratory Journal. Supplement|October 4, 2002
Clinical applications of assessment of airway inflammation using induced sputumI D Pavord, P J Sterk, F E Hargreave, et al.
The European Respiratory Journal|September 4, 2003
Murine models of asthmaJ C Kips, G P Anderson, J J Fredberg, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
American Journal of Respiratory and Critical Care Medicine|July 3, 1999
Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonistK N Parameswaran, M D Inman, B P Ekholm, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 27, 2008
Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison studyJ A Hirota, K Ask, D Fritz, et al.
Mucosal Immunology|August 16, 2013
Amelioration of ovalbumin-induced allergic airway disease following Der p 1 peptide immunotherapy is not associated with induction of IL-35D M Moldaver, M S Bharhani, J N Wattie, et al.
The Journal of Clinical Investigation|September 17, 1998
Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophiliaJ Wang, K Palmer, J Lŏtvall, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 17, 2015
T regulatory cell phenotypes in peripheral blood and bronchoalveolar lavage from non-asthmatic and asthmatic subjectsA J Baatjes, S G Smith, R Watson, et al.
Canadian Respiratory Journal|September 12, 2000
Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markersK Parameswaran, M D Inman, R M Watson, et al.
The European Respiratory Journal. Supplement|October 4, 2002
The use of induced sputum in clinical trialsJ C Kips, M D Inman, L Jayaram, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 10, 2002
Inhalation of a harmless antigen (ovalbumin) elicits immune activation but divergent immunoglobulin and cytokine activities in miceF K Swirski, B U Gajewska, D Alvarez, et al.
The European Respiratory Journal. Supplement|October 4, 2002
Clinical applications of assessment of airway inflammation using induced sputumI D Pavord, P J Sterk, F E Hargreave, et al.
The European Respiratory Journal|September 4, 2003
Murine models of asthmaJ C Kips, G P Anderson, J J Fredberg, et al.
Pageof 7